The role of Human Immunodeficiency Virus (HIV) asymptomatic status when starting antiretroviral therapy on adherence and treatment outcomes and implications for test and treat: the swiss HIV Cohort Study

Glass, Tracy R; Günthard, Huldrych F; Calmy, Alexandra; Bernasconi, Enos; Scherrer, Alexandra U; Battegay, Manuel; Steffen, Ana; Böni, Jürg; Yerly Ferrillo, Sabine; Klimkait, Thomas; Cavassini, Matthias; Furrer, Hansjakob

doi:10.1093/cid/ciaa239

Scientific article

English

The role of Human Immunodeficiency Virus (HIV) asymptomatic status when starting antiretroviral therapy on adherence and treatment outcomes and implications for test and treat: the swiss HIV Cohort Study

ContributorsGlass, Tracy R; Günthard, Huldrych F; Calmy, Alexandra

; Bernasconi, Enos; Scherrer, Alexandra U; Battegay, Manuel; Steffen, Ana; Böni, Jürg; Yerly Ferrillo, Sabine; Klimkait, Thomas; Cavassini, Matthias; Furrer, Hansjakob

Published inClinical Infectious Diseases, vol. 72, no. 8, p. 1413-1421

Publication date2021

Abstract

Since the advent of universal test-and-treat , more people living with human immunodeficiency virus (PLHIV) initiating antiretroviral therapy (ART) are asymptomatic with a preserved immune system. We explored the impact of asymptomatic status on adherence and clinical outcomes.

Keywords

Anti-HIV Agents/therapeutic use
Cohort Studies
HIV
HIV Infections/drug therapy/epidemiology
Homosexuality
Male
Humans
Male
Medication Adherence
Sexual and Gender Minorities
Switzerland/epidemiology
Treatment Outcome
Viral Load

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Citation (ISO format)

GLASS, Tracy R et al. The role of Human Immunodeficiency Virus (HIV) asymptomatic status when starting antiretroviral therapy on adherence and treatment outcomes and implications for test and treat: the swiss HIV Cohort Study. In: Clinical Infectious Diseases, 2021, vol. 72, n° 8, p. 1413–1421. doi: 10.1093/cid/ciaa239

Article (Published version)

Identifiers

PID : unige:157078
DOI : 10.1093/cid/ciaa239
PMID : 32157270

Journal ISSN1058-4838

168views

0downloads

Creation21/09/2021 12:34:00

First validation21/09/2021 12:34:00

Update10/02/2026 08:14:37

Status update10/02/2026 08:14:37

Last indexation10/02/2026 08:17:25

Archive ouverte UNIGE

The role of Human Immunodeficiency Virus (HIV) asymptomatic status when starting antiretroviral therapy on adherence and treatment outcomes and implications for test and treat: the swiss HIV Cohort Study

Since the advent of universal test-and-treat , more people living with human immunodeficiency virus (PLHIV) initiating antiretroviral therapy (ART) are asymptomatic with a preserved immune system. We explored the impact of asymptomatic status on adherence and clinical outcomes.

Technical informations